AVOPEF
Live / Applied — First extension granted (statement of use) (as of 12 Jan 2026)
What this means for you
Not registered yet, but its 24 Mar 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99099797
- Mark type
- Stylized text
- Filed
- 24 Mar 2025
- Published for opposition
- 08 Jul 2025
- Attorney of record
- R. Scott Keller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer
Owner
- Avyxa Pharma LLC, Parsippany, NJ, US
- Avyxa Pharma LLC, Parsippany, NJ, US
Prosecution history
- 13 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jan 2026 — SOU EXTENSION 1 GRANTED
- 12 Jan 2026 — SOU EXTENSION 1 FILED
- 12 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 02 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Jul 2025 — PUBLISHED FOR OPPOSITION
- 02 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Jun 2025 — ASSIGNED TO EXAMINER
- 24 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 24 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Mar 2025 — NEW APPLICATION ENTERED